替米沙坦市場報告（按適應症（高血壓、降低心血管風險）、配銷通路（醫院藥房、藥房和零售藥房、網路商店）和地區分類，2025 年至 2033 年

2024 年全球替米沙坦市場規模達 38.3 億美元。展望未來， IMARC Group預計到 2033 年市場規模將達到 48.2 億美元，2025-2033 年期間的成長率 (CAGR) 為 2.59%。

替米沙坦是一種非胜肽類血管張力素受體阻斷劑 (ARB)，作為處方藥用於治療高血壓和心血管疾病。它通常以片劑和口服油混懸劑的形式存在，並與其他藥物聯合使用以增強療效。它具有抗高血壓特性，並抑制體內醛固酮的生成，從而減少鈉和水的吸收，最終降低血壓。替米沙坦還能舒張血管，促進腎功能。然而，它可能引起各種副作用，例如頭暈、頭重腳輕、咳嗽和鼻竇疼痛。

替米沙坦市場趨勢：

全球製藥業的顯著成長是市場前景樂觀的關鍵因素之一。此外，高血壓、糖尿病和各種腎臟相關疾病的日益普及也推動了市場的成長。替米沙坦已被證明能夠有效改變胰島素增敏基因，並調節血糖和脂質代謝，有助於控制慢性糖尿病腎病變以及久坐不動的生活方式引起的其他疾病。製藥商也正在推出替米沙坦學名藥，以提供經濟有效的高血壓和心血管疾病治療方案。此外，製藥商正在大力投資用於治療糖尿病腎病變的先進替米沙坦藥物的研發，這也促進了市場的成長。老年人口的成長以及醫療基礎設施的顯著改善等其他因素預計將進一步推動市場的發展。

本報告回答的關鍵問題：

• 到目前為止，全球替米沙坦市場表現如何，未來幾年將如何表現？
• COVID-19 對全球替米沙坦市場有何影響？
• 主要的區域市場有哪些？
• 根據該跡象，市場將如何分化？
• 根據配銷通路，市場是如何分類的？
• 該產業的價值鏈分為哪些階段？
• 該行業的主要促進因素和挑戰是什麼？
• 全球替米沙坦市場的結構是怎麼樣的？主要參與者是誰？
• 產業競爭程度如何？

目錄

第1章：前言

第2章：範圍與方法

• 研究目標
• 利害關係人
• 資料來源
  • 主要來源
  • 二手資料
• 市場評估
  • 自下而上的方法
  • 自上而下的方法
• 預測方法

第3章：執行摘要

第4章：簡介

第5章：全球替米沙坦市場

• 市場概況
• 市場表現
• COVID-19的影響
• 市場預測

第6章：市場區隔：依指標

• 高血壓
• 降低心血管風險

第7章：市場區隔：按配銷通路

• 醫院藥房
• 藥局和零售藥房
• 網路商店

第8章：市場區隔：依地區

• 北美洲
  • 美國
  • 加拿大
• 亞太
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳洲
  • 印尼
  • 其他
• 歐洲
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 俄羅斯
  • 其他
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他
• 中東和非洲

第9章：SWOT分析

第 10 章：價值鏈分析

第 11 章：波特五力分析

第 12 章：價格分析

第 13 章：競爭格局

• 市場結構
• 關鍵參與者
• 關鍵參與者簡介
  • Abbott Laboratories
  • Aurobindo Pharma USA
  • Boehringer Ingelheim International GmbH
  • Cipla Limited
  • Hikma Pharmaceuticals plc
  • Jubilant Cadista Pharmaceutical
  • Sanofi SA
  • Solco Healthcare (Prinston Pharmaceutical Inc.)
  • Torrent Pharmaceuticals Ltd

The global telmisartan market size reached USD 3.83 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.82 Billion by 2033, exhibiting a growth rate (CAGR) of 2.59% during 2025-2033.

Telmisartan is a non-peptide angiotensin receptor blocker (ARB), which is used as a prescription drug for the treatment of hypertension and cardiovascular disorders. It is commonly available in tablets and oral oil suspension variants and is administered with other medications to enhance its efficacy. It exhibits antihypertensive properties and inhibits aldosterone production in the body, thereby leading to a decrease in sodium and water absorption and subsequent reduction in the blood pressure. Telmisartan also relaxes the blood vessels and promotes kidney function. However, it may cause various side effects, such as dizziness, lightheadedness, cough and sinus pain.

Telmisartan Market Trends:

Significant growth in the pharmaceutical industry across the globe is one of the key factors creating a positive outlook for the market. Moreover, the increasing prevalence of high blood pressure, diabetes and various kidney-related disorders is providing a thrust to the market growth. Telmisartan has been proven effective in modifying genes for insulin sensitization and regulating glucose and lipid metabolism, which aids in managing chronic diabetic kidney disease and other disorders caused by sedentary lifestyles. Pharmaceutical manufacturers are also launching generic versions of telmisartan medications to provide cost-effective treatment to hypertension and cardiovascular ailments. Additionally, drug manufacturers are investing significantly in the research and development (R&D) of advanced telmisartan medications for the treatment of diabetic nephropathy, which is also contributing to the growth of the market. Other factors, including the rising geriatric population, along with significant improvements in the healthcare infrastructure, are anticipated to drive the market further.

Key Market Segmentation:

Breakup by Indication:

• Hypertension
• Cardiovascular Risk Reduction

Breakup by Distribution Channel:

• Hospital Pharmacies
• Drug Stores and Retail Pharmacies
• Online Stores

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Aurobindo Pharma USA, Boehringer Ingelheim International GmbH, Cipla Limited, Hikma Pharmaceuticals plc, Jubilant Cadista Pharmaceutical, Sanofi S.A., Solco Healthcare (Prinston Pharmaceutical Inc.) and Torrent Pharmaceuticals Ltd.

Key Questions Answered in This Report:

• How has the global telmisartan market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global telmisartan market?
• What are the key regional markets?
• What is the breakup of the market based on the indication?
• What is the breakup of the market based on the distribution channel?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global telmisartan market and who are the key players?
• What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Telmisartan Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Indication

• 6.1 Hypertension
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Cardiovascular Risk Reduction
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Distribution Channel

• 7.1 Hospital Pharmacies
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Drug Stores and Retail Pharmacies
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Online Stores
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by Region

• 8.1 North America
  • 8.1.1 United States
    • 8.1.1.1 Market Trends
    • 8.1.1.2 Market Forecast
  • 8.1.2 Canada
    • 8.1.2.1 Market Trends
    • 8.1.2.2 Market Forecast
• 8.2 Asia-Pacific
  • 8.2.1 China
    • 8.2.1.1 Market Trends
    • 8.2.1.2 Market Forecast
  • 8.2.2 Japan
    • 8.2.2.1 Market Trends
    • 8.2.2.2 Market Forecast
  • 8.2.3 India
    • 8.2.3.1 Market Trends
    • 8.2.3.2 Market Forecast
  • 8.2.4 South Korea
    • 8.2.4.1 Market Trends
    • 8.2.4.2 Market Forecast
  • 8.2.5 Australia
    • 8.2.5.1 Market Trends
    • 8.2.5.2 Market Forecast
  • 8.2.6 Indonesia
    • 8.2.6.1 Market Trends
    • 8.2.6.2 Market Forecast
  • 8.2.7 Others
    • 8.2.7.1 Market Trends
    • 8.2.7.2 Market Forecast
• 8.3 Europe
  • 8.3.1 Germany
    • 8.3.1.1 Market Trends
    • 8.3.1.2 Market Forecast
  • 8.3.2 France
    • 8.3.2.1 Market Trends
    • 8.3.2.2 Market Forecast
  • 8.3.3 United Kingdom
    • 8.3.3.1 Market Trends
    • 8.3.3.2 Market Forecast
  • 8.3.4 Italy
    • 8.3.4.1 Market Trends
    • 8.3.4.2 Market Forecast
  • 8.3.5 Spain
    • 8.3.5.1 Market Trends
    • 8.3.5.2 Market Forecast
  • 8.3.6 Russia
    • 8.3.6.1 Market Trends
    • 8.3.6.2 Market Forecast
  • 8.3.7 Others
    • 8.3.7.1 Market Trends
    • 8.3.7.2 Market Forecast
• 8.4 Latin America
  • 8.4.1 Brazil
    • 8.4.1.1 Market Trends
    • 8.4.1.2 Market Forecast
  • 8.4.2 Mexico
    • 8.4.2.1 Market Trends
    • 8.4.2.2 Market Forecast
  • 8.4.3 Others
    • 8.4.3.1 Market Trends
    • 8.4.3.2 Market Forecast
• 8.5 Middle East and Africa
  • 8.5.1 Market Trends
  • 8.5.2 Market Breakup by Country
  • 8.5.3 Market Forecast

9 SWOT Analysis

• 9.1 Overview
• 9.2 Strengths
• 9.3 Weaknesses
• 9.4 Opportunities
• 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

• 11.1 Overview
• 11.2 Bargaining Power of Buyers
• 11.3 Bargaining Power of Suppliers
• 11.4 Degree of Competition
• 11.5 Threat of New Entrants
• 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

• 13.1 Market Structure
• 13.2 Key Players
• 13.3 Profiles of Key Players
  • 13.3.1 Abbott Laboratories
    • 13.3.1.1 Company Overview
    • 13.3.1.2 Product Portfolio
    • 13.3.1.3 Financials
    • 13.3.1.4 SWOT Analysis
  • 13.3.2 Aurobindo Pharma USA
    • 13.3.2.1 Company Overview
    • 13.3.2.2 Product Portfolio
    • 13.3.2.3 Financials
  • 13.3.3 Boehringer Ingelheim International GmbH
    • 13.3.3.1 Company Overview
    • 13.3.3.2 Product Portfolio
  • 13.3.4 Cipla Limited
    • 13.3.4.1 Company Overview
    • 13.3.4.2 Product Portfolio
    • 13.3.4.3 Financials
    • 13.3.4.4 SWOT Analysis
  • 13.3.5 Hikma Pharmaceuticals plc
    • 13.3.5.1 Company Overview
    • 13.3.5.2 Product Portfolio
    • 13.3.5.3 Financials
    • 13.3.5.4 SWOT Analysis
  • 13.3.6 Jubilant Cadista Pharmaceutical
    • 13.3.6.1 Company Overview
    • 13.3.6.2 Product Portfolio
  • 13.3.7 Sanofi S.A.
    • 13.3.7.1 Company Overview
    • 13.3.7.2 Product Portfolio
    • 13.3.7.3 Financials
    • 13.3.7.4 SWOT Analysis
  • 13.3.8 Solco Healthcare (Prinston Pharmaceutical Inc.)
    • 13.3.8.1 Company Overview
    • 13.3.8.2 Product Portfolio
  • 13.3.9 Torrent Pharmaceuticals Ltd
    • 13.3.9.1 Company Overview
    • 13.3.9.2 Product Portfolio
    • 13.3.9.3 Financials
    • 13.3.9.4 SWOT Analysis

List of Figures

• Figure 1: Global: Telmisartan Market: Major Drivers and Challenges
• Figure 2: Global: Telmisartan Market: Sales Value (in Billion USD), 2019-2024
• Figure 3: Global: Telmisartan Market Forecast: Sales Value (in Billion USD), 2025-2033
• Figure 4: Global: Telmisartan Market: Breakup by Indication (in %), 2024
• Figure 5: Global: Telmisartan Market: Breakup by Distribution Channel (in %), 2024
• Figure 6: Global: Telmisartan Market: Breakup by Region (in %), 2024
• Figure 7: Global: Telmisartan (Hypertension) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 8: Global: Telmisartan (Hypertension) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 9: Global: Telmisartan (Cardiovascular Risk Reduction) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 10: Global: Telmisartan (Cardiovascular Risk Reduction) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 11: Global: Telmisartan (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 12: Global: Telmisartan (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 13: Global: Telmisartan (Drug Stores and Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 14: Global: Telmisartan (Drug Stores and Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 15: Global: Telmisartan (Online Stores) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 16: Global: Telmisartan (Online Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 17: North America: Telmisartan Market: Sales Value (in Million USD), 2019 & 2024
• Figure 18: North America: Telmisartan Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 19: United States: Telmisartan Market: Sales Value (in Million USD), 2019 & 2024
• Figure 20: United States: Telmisartan Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 21: Canada: Telmisartan Market: Sales Value (in Million USD), 2019 & 2024
• Figure 22: Canada: Telmisartan Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 23: Asia-Pacific: Telmisartan Market: Sales Value (in Million USD), 2019 & 2024
• Figure 24: Asia-Pacific: Telmisartan Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 25: China: Telmisartan Market: Sales Value (in Million USD), 2019 & 2024
• Figure 26: China: Telmisartan Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 27: Japan: Telmisartan Market: Sales Value (in Million USD), 2019 & 2024
• Figure 28: Japan: Telmisartan Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 29: India: Telmisartan Market: Sales Value (in Million USD), 2019 & 2024
• Figure 30: India: Telmisartan Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 31: South Korea: Telmisartan Market: Sales Value (in Million USD), 2019 & 2024
• Figure 32: South Korea: Telmisartan Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 33: Australia: Telmisartan Market: Sales Value (in Million USD), 2019 & 2024
• Figure 34: Australia: Telmisartan Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 35: Indonesia: Telmisartan Market: Sales Value (in Million USD), 2019 & 2024
• Figure 36: Indonesia: Telmisartan Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 37: Others: Telmisartan Market: Sales Value (in Million USD), 2019 & 2024
• Figure 38: Others: Telmisartan Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 39: Europe: Telmisartan Market: Sales Value (in Million USD), 2019 & 2024
• Figure 40: Europe: Telmisartan Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 41: Germany: Telmisartan Market: Sales Value (in Million USD), 2019 & 2024
• Figure 42: Germany: Telmisartan Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 43: France: Telmisartan Market: Sales Value (in Million USD), 2019 & 2024
• Figure 44: France: Telmisartan Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 45: United Kingdom: Telmisartan Market: Sales Value (in Million USD), 2019 & 2024
• Figure 46: United Kingdom: Telmisartan Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 47: Italy: Telmisartan Market: Sales Value (in Million USD), 2019 & 2024
• Figure 48: Italy: Telmisartan Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 49: Spain: Telmisartan Market: Sales Value (in Million USD), 2019 & 2024
• Figure 50: Spain: Telmisartan Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 51: Russia: Telmisartan Market: Sales Value (in Million USD), 2019 & 2024
• Figure 52: Russia: Telmisartan Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 53: Others: Telmisartan Market: Sales Value (in Million USD), 2019 & 2024
• Figure 54: Others: Telmisartan Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 55: Latin America: Telmisartan Market: Sales Value (in Million USD), 2019 & 2024
• Figure 56: Latin America: Telmisartan Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 57: Brazil: Telmisartan Market: Sales Value (in Million USD), 2019 & 2024
• Figure 58: Brazil: Telmisartan Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 59: Mexico: Telmisartan Market: Sales Value (in Million USD), 2019 & 2024
• Figure 60: Mexico: Telmisartan Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 61: Others: Telmisartan Market: Sales Value (in Million USD), 2019 & 2024
• Figure 62: Others: Telmisartan Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 63: Middle East and Africa: Telmisartan Market: Sales Value (in Million USD), 2019 & 2024
• Figure 64: Middle East and Africa: Telmisartan Market: Breakup by Country (in %), 2024
• Figure 65: Middle East and Africa: Telmisartan Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 66: Global: Telmisartan Industry: SWOT Analysis
• Figure 67: Global: Telmisartan Industry: Value Chain Analysis
• Figure 68: Global: Telmisartan Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Telmisartan Market: Key Industry Highlights, 2024 and 2033
• Table 2: Global: Telmisartan Market Forecast: Breakup by Indication (in Million USD), 2025-2033
• Table 3: Global: Telmisartan Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
• Table 4: Global: Telmisartan Market Forecast: Breakup by Region (in Million USD), 2025-2033
• Table 5: Global: Telmisartan Market: Competitive Structure
• Table 6: Global: Telmisartan Market: Key Players